Maqola

MARKETING ANALYSIS OF DRUGS USED FOR VIRAL HEPATITIS IN THE REPUBLIC OF UZBEKISTAN

Gulchexra MamatisakovaAziza TuxtayevaRano AlievaCandidate of Pharmaceutical Sciences, Dotcent, Tashkent Pharmaceutical Institute, Uzbekistan, Tashkent

Universum Medicine & pharmacologyjournal2021en

ABI

Annotatsiya

An marketing analysis of hepatoprotectors of the Republic of Uzbekistan was carried out according to the State registers of medicines and medical devices No. 22 for 2018; No.23 for 2019; No24 for 2020 according to research. Medicines for the treatment of viral hepatitis. 2018-2019 of the total number of 28.7% is accounted for by domestic producers. The number of drugs for the treatment of viral hepatitis of domestic pharmaceutical manufacturers 2018-2020 increased from 30 to 31 positions.

Hali tarjima qilinmagan

Mavzular

Education, Innovation and Language Studies Economic and Industrial Development Economic, Social, and Public Health Issues in Russia and Globally

Identifikatorlar

DOI: 10.32743/unimed.2021.78.6.11900

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba

Koʻrsatkichlar — AkademScholar · Tez orada